ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study

Autor: Righi, S., Fiorini, E. ^∗, De Molo, C., Cipriano, V., Cassani, F., Muratori, L., Lenzi, M., Morselli Labate, A.M., Serra, C.

Publikováno v: In Journal of Ultrasound December 2012 15(4):226-231

Liver HCV-antigens and steatosis in chronic hepatitis C: Role of different genotypes

Autor: Grassi, A. ^{a, ⁎}, Cipriano, V. ^b, Quarneti, C. ^b, Bianchini, F. ^b, Susca, M. ^b, Zauli, D. ^b, Lenzi, M. ^b, Bianchi, G. ^c, Bianchi, F.B. ^b, Ballardini, G. ^a

Publikováno v: In Digestive and Liver Disease 2009 41(9):659-664

Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

Autor: Bruno, S, Bollani, S., Zignego, A. L., Pascasio, J. M., Magni, C., Ciancio, A., Caremani, M., Mangia, A., Marenco, S., Piovesan, S., Chemello, L., Babudieri, S., Moretti, A., Gea, F., Colletta, C., Perez Alvarez, R., Forns, X., Larrubia, J. R., Arenas, J., Crespo, J., Calvaruso, V., Ceccherini Silberstein, F., Maisonneuve, P., Craxì, A., Calleja, J. L., Di Marco, V., Monti, M., Rizzardini, G., Landonio, S., Rizzetto, M., Lapini, L. E., Piazzolla, V., Picciotto, A., Alberti, A., Cavaletto, L., Koch, M., Massari, M., Muratori, L., Cipriano, V., Montineri, A., Iacobello, C., Fangazio, S., Pirisi, M., Colombo, A., Bellati, G., Mazzotta, F., Pierotti, P., Traverso, A., Serviddio, G., Russello, M., Santantonio, T., Drenaggi, D., Marchionne, E., Zuin, M., Delliponti, M., Farina, F., Andreone, P., Scuteri, A., Galli, M., Giannini, EDOARDO GIOVANNI, Nerli, A., Carbonai, S., Coppola, N., Montalbano, M., Portelli, V., Di Biagio, A., Nicolini, LAURA AMBRA, Mastroianni, C., Madonia, S., Licata, A., Montalto, G., Giannitrapani, L., Mondelli, M., Pellicelli, A., Toniutto, P., Borgia, G., Gentile, I., De Luca, M., Di Costanzo, G. G., Corti, G., Sousa, M., Delgado, M. B., De La Revilla, J., Navarro, J. M., Barcena, R., Romero Gomez, M., Fernandez Rodriguez, C. M., Narvaez, I., Erdozain, J. C., Molina, E., Fernandez, I., Cuenca, B., Planas, R., Garcia Samaniego, J., Ladero, J. M., Gonzalez, J. M., Serra, M. A., Castellote, I., Sola, R., Anton, T., Ryan, I., Gonzalez, F., Martinez, E., Portu, J.

In many countries, first-generation protease inhibitors (PIs)/peginterferon/ribavirin (P/R) still represent the only treatment option for HCV-infected patients. Subjects with advanced disease and previous failure to P/R urgently need therapy, but the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55eee2a0c597fb9dbf1b0b00fe79cea9
http://hdl.handle.net/11390/1190517

Primary biliary cholangitis has causal effects on systemic rheumatic diseases: a Mendelian randomization study.

Autor: Zhang, Hai-Ping¹ (AUTHOR), Zhou, Zhe² (AUTHOR), Chen, Ke¹ (AUTHOR), Xiong, Li-Fen¹ (AUTHOR), Wu, Jun¹ (AUTHOR), Jin, Lei¹ (AUTHOR) 15634619@qq.com

Publikováno v: BMC Gastroenterology. 8/29/2024, Vol. 24 Issue 1, p1-7. 7p.

Suing Cities.

Autor: CLOPTON, ZACHARY D.¹, SHOKED, NADAV¹

Publikováno v: Yale Law Journal. Jun2024, Vol. 133 Issue 8, p2540-2612. 73p.